Armistice Capital, LLC 13D and 13G filings for InMed Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:36 pm Purchase |
2024-09-30 | 13G | InMed Pharmaceuticals Inc. INM |
Armistice Capital, LLC | 34,816 4.990% |
33,300 (+2197.27%) |
Filing |
| 2024-02-14 2:28 pm Purchase |
2023-12-31 | 13G | InMed Pharmaceuticals Inc. INM |
Armistice Capital, LLC | 1,516 9.990% |
1,101 (+265.88%) |
Filing |
| 2023-02-14 12:58 pm Purchase |
2022-12-31 | 13G | InMed Pharmaceuticals Inc. INM |
Armistice Capital, LLC | 414 9.990% |
414 (New Position) |
Filing |